Brainstorm cell therapeutics to participate in the 2022 virtual growth conference presented by maxim group llc and hosted by m-vest on march 28th - 30th from 9:00 a.m. - 5:00 p.m.

New york, march 28, 2022 /prnewswire/ -- brainstorm cell therapeutics (nasdaq: bcli), a leading developer of cellular therapies for neurodegenerative disease, announced today that the company president and chief medical officer, ralph kern, md mhsc has been invited to present at the 2022 virtual growth conference, presented by maxim group llc and hosted by m-vest, on march 28th - 30th   from 9:00 a.m. - 5:00 p.m.
BCLI Ratings Summary
BCLI Quant Ranking